4.5 Article Proceedings Paper

Characteristics of patients with hospital-acquired influenza A (H1N1) pdm09 virus admitted to the intensive care unit

期刊

JOURNAL OF HOSPITAL INFECTION
卷 95, 期 2, 页码 200-206

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2016.12.017

关键词

Infuenza A virus; H1N1 subtype; Nosocomial infection; Community-acquired infections; Mortality; Critically ill

资金

  1. Fundacio IMIM, Barcelona, Spain

向作者/读者索取更多资源

Background: Influenza A (H1N1) pdm09 virus infection acquired in the hospital and in critically ill patients admitted to the intensive care unit (ICU) has been poorly characterized. Aim: To assess the clinical impact of hospital-acquired infection with influenza A (H1N1) pdm09 virus in critically ill patients. Methods: Analysis of a prospective database of the Spanish registry (2009-2015) of patients with severe influenza A admitted to the ICU. Infection was defined as hospitalacquired when diagnosis and starting of treatment occurred from the seventh day of hospital stay with no suspicion on hospital admission, and community-acquired when diagnosis was established within the first 48 h of admission. Findings: Of 2421 patients with influenza A (H1N1) pdm09 infection, 224 (9.3%) were classified as hospital-acquired and 1103 (45.6%) as community-acquired (remaining cases unclassified). Intra-ICU mortality was higher in the hospital-acquired group (32.9% vs 18.8%, P < 0.001). Independent factors associated with mortality were hospital-acquired influenza A (H1N1) pdm09 infection (odds ratio: 1.63; 95% confidence interval: 1.37-1.99), APACHE II score on ICU admission (1.09; 1.06-1.11), underlying haematological disease (3.19; 1.78-5.73), and need of extrarenal depuration techniques (4.20; 2.61-6.77) and mechanical ventilation (4.34; 2.62-7.21). Conclusion: Influenza A (H1N1) pdm09 infection acquired in the hospital is an independent factor for death in critically ill patients admitted to the ICU. (C) 2017 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Respiratory System

Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study

Anna Motos, Alexandre Lopez-Gavin, Jordi Riera, Adrian Ceccato, Laia Fernandez-Barat, Jesus F. Bermejo-Martin, Ricard Ferrer, David de Gonzalo-Calvo, Rosario Menendez, Raquel Perez-Arnal, Dario Garcia-Gasulla, Alejandro Rodriguez, Oscar Penuelas, Jose Angel Lorente, Raquel Almansa, Albert Gabarrus, Judith Marin-Corral, Pilar Ricart, Ferran Roche-Campo, Susana Sancho Chinesta, Lorenzo Socias, Ferran Barbe, Antoni Torres

EUROPEAN RESPIRATORY JOURNAL (2022)

Letter Critical Care Medicine

One-year mortality after ICU admission due to COVID-19 infection

Adrian Ceccato, Raquel Perez-Arnal, Anna Motos, Ferran Barbe, Antoni Torres

INTENSIVE CARE MEDICINE (2022)

Article Critical Care Medicine

A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

G. Moreno, M. Ruiz-Botella, I Martin-Loeches, J. Gomez Alvarez, M. Jimenez Herrera, M. Bodi, F. Armestar, A. Marques Parra, A. Estella, S. Trefler, R. Jorge Garcia, J. Murcia Paya, P. Vidal Cortes, E. Diaz, R. Ferrer, A. Albaya-Moreno, L. Socias-Crespi, J. M. Bonell Goytisolo, S. Sancho Chinesta, A. Loza, L. Forcelledo Espina, J. C. Pozo Laderas, M. DeAlba-Aparicio, L. Sanchez Montori, I Vallverdu Perapoch, V Hidalgo, V Fraile Gutierrez, A. M. Casamitjana Ortega, F. Martin Serrano, M. Nieto, M. Blasco Cortes, J. Marin-Corral, J. Sole-Violan, A. Rodriguez

Summary: This study aimed to determine the association between corticosteroid use and ICU mortality in both the whole population and pre-specified clinical phenotypes. The results showed that corticosteroids were not associated with ICU mortality in the overall population, but they may have a protective effect in patients with the highest inflammatory levels.

MEDICINA INTENSIVA (2023)

Article Medicine, General & Internal

ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome

Ignacio Martin-Loeches, Anna Motos, Rosario Menendez, Albert Gabarrus, Jessica Gonzalez, Laia Fernandez-Barat, Adrian Ceccato, Raquel Perez-Arnal, Dario Garcia-Gasulla, Ricard Ferrer, Jordi Riera, Jose Angel Lorente, Oscar Penuelas, Jesus F. Bermejo-Martin, David de Gonzalo-Calvo, Alejandro Rodriguez, Ferran Barbe, Luciano Aguilera, Rosario Amaya-Villar, Carme Barbera, Jose Barberan, Aaron Blandino Ortiz, Elena Bustamante-Munguira, Jesus Caballero, Cristina Carbajales, Nieves Carbonell, Mercedes Catalan-Gonzalez, Cristobal Galban, Victor D. Gumucio-Sanguino, Maria del Carmen de la Torre, Emili Diaz, Elena Gallego, Jose Luis Garcia Garmendia, Jose Garnacho-Montero, Jose M. Gomez, Ruth Noemi Jorge Garcia, Ana Loza-Vazquez, Judith Marin-Corral, Amalia Martinez de la Gandara, Ignacio Martinez Varela, Juan Lopez Messa, Guillermo M. Albaiceta, Mariana Andrea Novo, Yhivian Penasco, Pilar Ricart, Luis Urrelo-Cerron, Angel Sanchez-Miralles, Susana Sancho Chinesta, Lorenzo Socias, Jordi Sole-Violan, Luis Tamayo Lomas, Pablo Vidal, Antoni Torres

Summary: Persistent post-COVID-19 symptoms were found in more than two-thirds of patients, with female sex, duration of ICU stay, development of ICUAP, and ARDS identified as independent factors contributing to poor health post-COVID-19. Preventing ICUAP may have beneficial effects on post-COVID-19 recovery.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Nutrition & Dietetics

Evaluation of Nutritional Practices in the Critical Care patient (The ENPIC study): Does nutrition really affect ICU mortality?

Lluis Servia-Goixart, Juan C. Lopez-Delgado, Teodoro Grau-Carmona, Javier Trujillano-Cabello, M. Luisa Bordeje-Laguna, Esther Mor-Marco, Esther Portugal-Rodriguez, Carol Lorencio-Cardenas, Juan C. Montejo-Gonzalez, Paula Vera-Artazcoz, Laura Macaya-Redin, Juan Francisco Martinez-Carmona, Rayden Iglesias-Rodriguez, Diana Monge-Donaire, Jose L. Flordelis-Lasierra, Beatriz Llorente-Ruiz, Eva M. Menor-Fernandez, Itziar Martinez de Lagran, Juan C. Yebenes-Reyes

Summary: This study aimed to evaluate the influence of nutritional therapy on mortality in critically ill patients. The results showed that factors such as age, organ failure scores, nutritional risk, and the need for parenteral nutrition were associated with mortality. Furthermore, mean calorie and protein intake may also influence outcomes.

CLINICAL NUTRITION ESPEN (2022)

Letter Nursing

In response to Intensive care nurse perspectives on open visiting in an ICU

F. Vela-Cano, D. Ruiz-Sanchez, J. Granado-Solano, A. Garcia-Sanz, M. Ortega-Botias, J. Marin-Corral

ENFERMERIA INTENSIVA (2022)

Article Chemistry, Analytical

Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers

Alex Gomez-Gomez, Jose Rodriguez-Morato, Noemi Haro, Judith Marin-Corral, Joan Ramon Masclans, Oscar J. Pozo

Summary: Metabolomics, especially untargeted metabolomics, has become the gold standard for biomarker discovery. This study developed a strategy based on derivatization and LC-MS/MS detection for the untargeted determination of carbonyl-containing metabolites. The usefulness of this guided metabolomics approach was demonstrated in the discovery of potential biomarkers for COVID-19 severity.

ANALYTICA CHIMICA ACTA (2022)

Article Critical Care Medicine

Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19

Luis Felipe Reyes, Alejandro Rodriguez, Alirio Bastidas, Daniela Parra-Tanoux, Yuli Fuentes, Esteban Garcia-Gallo, Gerard Moreno, Gustavo Ospina-Tascon, Gleen Hernandez, Edwin Silva, Ana Maria Diaz, Manuel Jibaja, Magdalena Vera-Alarcon, Emilio Diaz, Maria Bodi, Jordi Sole-Violan, Ricard Ferrer, Antonio Albaya-Moreno, Lorenzo Socias, Angel Estella, Ana Loza-Vazquez, Ruth Jorge-Garcia, Isabel Sancho, Ignacio Martin-Loeches

Summary: This study found a relation between dexamethasone treatment and ICU-acquired respiratory tract infections (ICU-RTI) in patients with COVID-19. Patients treated with dexamethasone showed significantly higher proportions of VAP, and dexamethasone treatment was identified as a risk factor for ICU-RTI.

JOURNAL OF CRITICAL CARE (2022)

Article Respiratory System

Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

Sergi Pascual-Guardia, Francesco Amati, Judith Marin-Corral, Stefano Aliberti, Joaquim Gea, Nilam J. Soni, Alejandro Rodriguez, Oriol Sibila, Francisco Sanz, Giovanni Sotgiu, Pedro J. Marcos, Ane Uranga, Branislava Milenkovic, Christian N. Meyer, Martin Kolditz, Antonio R. Anzueto, Marcos I. Restrepo

Summary: This study aimed to assess the microbiological patterns associated with risk factors for empiric anti-pseudomonal antibiotic therapy in hospitalized COPD patients with CAP. By analyzing observational data from 689 hospitalized COPD patients, it was found that different microbiological profiles were present in COPD patients with CAP, and a new scoring system was proposed to guide decision-making about empiric anti-pseudomonal antibiotic therapy.

ARCHIVOS DE BRONCONEUMOLOGIA (2023)

Article Respiratory System

Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

Jessica Gonzalez, Jordi de Batlle, Ivan D. Benitez, Gerard Torres, Sally Santisteve, Adriano D. S. Targa, Clara Gort-Paniello, Anna Moncusi-Moix, Maria Aguila, Fatty Seck, Adrian Ceccato, Ricard Ferrer, Anna Motos, Jordi Riera, Laia Fernandez, Rosario Menendez, Jose Angel Lorente, Oscar Penuelas, Dario Garcia-Gasulla, Yhivian Penasco, Pilar Ricart, Elena Abril Palomares, Luciano Aguilera, Alejandro Rodriguez, Maria Victoria Boado Varela, Belen Betere, Juan Carlos Pozo-Laderas, Jordi Sole-Violan, Inmaculada Salvador-Adell, Mariana Andrea Novo, Jose Barberan, Rosario Amaya Villar, Jose Garnacho-Montero, Jose M. Gomez, Aaron Blandino Ortiz, Luis Tamayo Lomas, Alejandro Ubeda, Mercedes Catalan-Gonzalez, Angel Sanchez-Miralles, Ignacio Martinez Varela, Ruth Noemi Jorge Garcia, Nieves Franco, Victor D. Gumucio-Sanguino, Elena Bustamante-Munguira, Luis Jorge Valdivia, Jesus Caballero, Elena Gallego, Covadonga Rodriguez, Alvaro Castellanos-Ortega, Josep Trenado, Judith Marin-Corral, Guillermo M. Albaiceta, Maria del Carmen de la Torre, Ana Loza-Vazquez, Pablo Vidal, Jose M. Anon, Cristina Carbajales Perez, Victor Sagredo, Nieves Carbonell, Lorenzo Socias, Carme Barbera, Angel Estella, Emili Diaz, David de Gonzalo-Calvo, Antoni Torres, Ferran Barbe

Summary: A study found that critical COVID-19 survivors are at high risk of impaired lung function and CT scan abnormalities during follow-up. Key factors associated with DLCO < 60% include chronic lung disease, duration of invasive mechanical ventilation, age, urea, and estimated glomerular filtration rate. Factors associated with fibrotic lesions include bacterial pneumonia and duration of ventilation. Age and chronic lung disease are important factors associated with impaired lung function and CT abnormalities in critical COVID-19 patients.

ARCHIVOS DE BRONCONEUMOLOGIA (2023)

Letter Critical Care Medicine

Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

Jessica Gonzalez, Ivan D. Benitez, Anna Motos, Antoni Torres, Ferran Barbe

INTENSIVE CARE MEDICINE (2023)

Article Medicine, General & Internal

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Alisa M. Higgins, Lindsay R. Berry, Elizabeth Lorenzi, Srinivas Murthy, Zoe McQuilten, Paul R. Mouncey, Farah Al-Beidh, Djillali Annane, Yaseen M. Arabi, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Marc J. M. Bonten, Charlotte A. Bradbury, Frank M. Brunkhorst, Aiden Burrell, Adrian Buzgau, Meredith Buxton, Walton N. Charles, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Elizabeth O. Fagbodun, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, Christopher M. Horvat, David T. Huang, Nao Ichihara, Francois Lamontagne, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Bryan J. McVerry, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Karen Parry-Billings, Sam E. C. Peters, Luis F. Reyes, Kathryn M. Rowan, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Lucy M. Stronach, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Ryan Zarychanski, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Anthony C. Gordon, Steve A. Webb, Patrick R. Lawler

Summary: The longer-term effects of therapies for critically ill COVID-19 patients are unknown. In this study, 4869 patients were randomized to receive different interventions, and it was found that treatment with IL-6 receptor antagonists and antiplatelet agents significantly improved survival rates after 180 days. These findings suggest that most therapies have consistent effects over a 6-month period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Letter Infectious Diseases

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

Catia Cilloniz, Anna Motos, Tatiana Castaneda, Albert Gabarrus, Ferran Barbe, Antoni Torres

JOURNAL OF INFECTION (2023)

Review Critical Care Medicine

Cardiovascular Complications in Coronavirus Disease 2019-Pathogenesis and Management

Marcos I. Restrepo, Judith Marin-Corral, Juan J. Rodriguez, Valeria Restrepo, Rodrigo Cavallazzi

Summary: The COVID-19 pandemic has had devastating effects on global morbidity and mortality. The virus has a specific tropism for the cardiovascular system, causing endothelial injury and leading to inflammation, microthrombosis, and angiogenesis. The disease is associated with various cardiovascular complications such as myocarditis, arrhythmias, heart failure, ischemic heart disease, stroke, and thromboembolic disease. This review summarizes the literature on the epidemiology, diagnosis, treatment, and preventive measures related to cardiovascular complications in COVID-19.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Multidisciplinary Sciences

Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence

Tomas Segura, Ignacio Medrano, Sergio Collazo, Claudia Mate, Carlo Sguera, Carlos Del Rio-Bermudez, Hugo Casero, Ignacio Salcedo, Jorge Garcia-Garcia, Cristian Alcahut-Rodriguez, Miren Taberna

Summary: This study used real-world data to describe the clinical profile and timing of diagnosis in ALS patients. The results showed a significant diagnostic delay in ALS, with only 38.8% of patients visiting a neurologist prior to diagnosis. The study highlights the importance of early diagnosis and reveals differences in clinical characteristics across ALS subtypes.

SCIENTIFIC REPORTS (2023)

暂无数据